ISCO isn't a scam company. They have two subsidiaries bringing in revenue. But, research and trials are very expensive. Cost is why many companies are running clinical trials in Australia. Go to the links I've provided rather than just reading the titles.
I'm sure you've heard of astrazeneca. Here's their take on doing trials in Australia. https://www.astrazeneca.com.au/sustainability/About-us-research-development.html Quote: In partnership with doctors in Australia we focus our skills and resources on getting life-changing medicines to patients as quickly, safely and efficiently as possible. We are currently conducting research to develop new medicines in the following disease areas:
To find out more about clinical trials in Australia, please visit the dedicated Australian Government website www.australianclinicaltrials.gov.au
The Australian Government commits $100m to support rural, regional, and remote clinical trials – recognizing the importance of a “vibrant clinical trial ecosystem in underpinning a world-class health care system,” says industry expert.
As I said earlier, dilution has been the main problem here. Not unheard of in biotech. Biotech is very risky for early investors and I got involved way too early with this one. But, that is my fault, not the company's fault. It's been off my radar for awhile now, but, I'm watching again.
Market Data 
Markets 
AI
